BATCH OF 20 BELOTERO LIPS CONTOUR LIDO (1x0,6ml) MERZ AESTHETICS

BELOTERO LIPS CONTOUR LIDO (1x0,6ml) MERZ AESTHETIC

BY MERZ AESTHETICS PRODUCTS. WARNING: DISTRIBUTION FROM FRANCE TO U.S.A OF MERZ PORTOFLIO MEDICAL DEVICES SUCH AS BELOTERO, RADIESSE, ETERMIS IS PROHIBITED. IT'S A VIOLATION OF FDA LAW. ORDER WILL BE CANCELED. MEDICAL USE. BELOTERO LIPS CONTOUR LIDO must only be administered by a qualified practitioner or health professional. Class III medical device. CE (CE0120).

DESCRIPTION

• Designed to define the contour of the lips, soft mouth commissures. 
• BELOTERO LIPS CONTOUR is intended to give volume and sublimate the upper and lower lips. 
• Serile, transparent, colorless, pyrogen-free, viscoelastic gel composed of cross-linked sodium hyaluronate of non-animal origin, in a physiological phosphate buffer. 
• Contains 0.3% lidocaine hydrochloride.
• Optimum volume and definition for patient-specific results.
• BELOTERO LIPS CONTOUR is designed to define the outline of the lip  for a more youthful appearance.

PRESENTATION

• BELOTERO LIPS CONTOUR is presented in sterile, sterilized pre-filled single-use glass syringe.
• Each box contains a leaflet, a syringe, two traceability labels and two sterile needles labeled CE single use. The dimensions of the needles are indicated on the case.
• PACKAGE 1 X 0.6 ml.
• NEEDLE 27 G gold 30 G.

COMPOSITION

• Hyaluronate de sodium cross-linked 22,5 mg/ml + Lidocain 3mg/ml.
• Lidocaine Hydrochloride: 3.0 mg / ml.
• The presence of lidocaine makes it possible to locally reduce the pain associated with the injection of the gel and to improve the comfort of the patient.
• Phosphate buffer pH 7 QSP: Volume of the gel in a syringe.
• The volume of gel in each syringe is indicated on the holster.

INDICATION

• BELOTERO LIPS CONTOUR LIDOis an injectable and resorbable fillers indicated to correct atrophic scars of the face and to improve the appearance of the lips (eg: lip contour, superficial perioral wrinkles and moderate compression of the labial commissures). 
• The presence of lidocaine makes it possible to locally reduce the pain associated with the injection of the gel and to improve the comfort of the patient.

INJECTION SITE

Submucosal, superficial dermis with medium dermis.

FOCUS INDICATION

Contour of the lips, soft mouth commissures.

COMPARISON BETWEEN BELOTERO LIPS LIDO SHAPE AND CONTOUR

SHAPE LIDO

• HA 25.5 mg + LIDO.
• Needle: 27G.
• INJECTION SIDE: Submucosal.
• FOCUS INDICATION: Volume of the lips, severe mouth commissures.
• LIDOCAINE: Included

CONTOUR LIDO

• HA 22.5 mg + LIDO.
• Needle: 27 G or 30 G.
• SIDE INJECTION Superficial to middle dermis and submucosa.
• FOCUS INDICATION Contour of the lips, light mouth corners.
• LIDOCAINE: Included.